Cargando…

STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes

Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of chronic liver disease worldwide, primarily because of the massive global increase in obesity. Despite intense research efforts in this field, the factors that govern the initiation and subsequent progression of NAFLD are poor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caputo, Mara, Cansby, Emmelie, Kumari, Sima, Kurhe, Yeshwant, Nair, Syam, Ståhlman, Marcus, Kulkarni, Nagaraj M., Borén, Jan, Marschall, Hanns‐Ulrich, Blüher, Matthias, Mahlapuu, Margit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279465/ https://www.ncbi.nlm.nih.gov/pubmed/34278168 http://dx.doi.org/10.1002/hep4.1702

Ejemplares similares

Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice
por: Xia, Ying, et al.
Publicado: (2023)

Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring
por: Xia, Ying, et al.
Publicado: (2023)

STE20-type kinase TAOK3 regulates hepatic lipid partitioning
por: Xia, Ying, et al.
Publicado: (2021)

Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways
por: Kurhe, Yeshwant, et al.
Publicado: (2021)

GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond
por: Mahlapuu, Margit, et al.
Publicado: (2022)

Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage
por: Anand, Sumit Kumar, et al.
Publicado: (2022)

Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
por: Cansby, Emmelie, et al.
Publicado: (2018)

Silencing of STE20-type kinase STK25 in human aortic endothelial and smooth muscle cells is atheroprotective
por: Cansby, Emmelie, et al.
Publicado: (2022)

Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease
por: Cansby, Emmelie, et al.
Publicado: (2020)

Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
por: Nuñez-Durán, Esther, et al.
Publicado: (2017)

Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice
por: Nuñez‐Durán, Esther, et al.
Publicado: (2017)

Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle
por: Chursa, Urszula, et al.
Publicado: (2016)

Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model
por: Amrutkar, Manoj, et al.
Publicado: (2015)

Regulation of Proapoptotic Mammalian ste20–Like Kinase MST2 by the IGF1-Akt Pathway
por: Kim, Donghwa, et al.
Publicado: (2010)

Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways
por: Lorber, B., et al.
Publicado: (2009)

Retraction: Regulation of Proapoptotic Mammalian ste20–Like Kinase MST2 by the IGF1-Akt Pathway
Publicado: (2023)

Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice
por: Kurhe, Yeshwant, et al.
Publicado: (2016)

Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approach
por: Kurhe, Yeshwant, et al.
Publicado: (2017)

Metabolic Changes of Hepatocytes in NAFLD
por: Lu, Qianrang, et al.
Publicado: (2021)

Test System for the STE: STE 80366 CC Test
por: Larsen, H.
Publicado: (1986)

Mst1 and Mst2 kinases: regulations and diseases
por: Qin, Funiu, et al.
Publicado: (2013)

The Aspergillus nidulans MAPK Module AnSte11-Ste50-Ste7-Fus3 Controls Development and Secondary Metabolism
por: Bayram, Özgür, et al.
Publicado: (2012)

Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014)

Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats
por: Gupta, Deepali, et al.
Publicado: (2013)

Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
por: Gupta, Deepali, et al.
Publicado: (2015)

Personal model‐assisted identification of NAD(+) and glutathione metabolism as intervention target in NAFLD
por: Mardinoglu, Adil, et al.
Publicado: (2017)

Analysis of random PCR‐originated mutants of the yeast Ste2 and Ste3 receptors
por: Gastaldi, Serena, et al.
Publicado: (2016)

Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3
por: Gordon, Johnthan, et al.
Publicado: (2011)

Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice
por: Faizah, Zakiyatul, et al.
Publicado: (2020)

Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
por: Kurhe, Yeshwant Vijay, et al.
Publicado: (2014)

Ste Barbe 01 98
Publicado: (1998)

Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex
por: Abou Nader, Nour, et al.
Publicado: (2022)

Survey of MST Studies
por: Barbalat, O
Publicado: (1974)

Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation
por: Li, Peng, et al.
Publicado: (2013)

Mst1 and Mst2 Are Essential Regulators of Trophoblast Differentiation and Placenta Morphogenesis
por: Du, Xingrong, et al.
Publicado: (2014)

Web viert 20ste verjaardag
Publicado: (2009)

Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial
por: Friedrich, Dana, et al.
Publicado: (2018)

MST kinases in development and disease
por: Thompson, Barry J., et al.
Publicado: (2015)

The kinases Mst1 and Mst2 positively regulate phagocyte ROS induction and bactericidal activity
por: Geng, Jing, et al.
Publicado: (2015)

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
por: Régnier, Marion, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qmu2q4g0jikl5k3peohsdceed4